Arcturus Therapeutics Holdings Inc (NAS:ARCT)
$ 17.9 -0.74 (-3.97%) Market Cap: 484.87 Mil Enterprise Value: 297.15 Mil PE Ratio: 0 PB Ratio: 1.85 GF Score: 77/100

Arcturus Therapeutics Holdings Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 10, 2021 / 06:50PM GMT
Release Date Price: $48.17 (-0.45%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Good afternoon, everyone. My name is Gena Wang. I'm a SMid-cap biotech analyst at the Barclays. Welcome to our Second Virtual Global Healthcare Conference. First, I wish you -- you must stay healthy. And I would like to thank all the participants, investors, company and especially our event team and corporate execs team who made this virtual health care conference possible.

With that, I would like to introduce our next presenter, Joe Payne, Chief Executive Officer of Arcturus. Joe, maybe I will hand over to you to give a few minutes of high-level overview about the company, and then we can go to the Q&A.

Joseph E. Payne
Arcturus Therapeutics Holdings Inc. - Founder, President, CEO & Director

Sure. Thanks, Gena, and it's good to be with you, and appreciate the time. Hi, everyone. My name is Joe Payne. I'm the President and CEO of Arcturus. Arcturus has been around since 2013. We're a clinical stage messenger RNA medicines and vaccines company, a therapeutics and vaccines

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot